Inventor · Conshohocken, PA, US

Peter Ronald Young

47Patents
17h-index
63Co-inventors
84Inventor score

Filing activity: May 31, 1994 → Jul 12, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US5783181A Therapeutic uses of fusion proteins between mutant IL 4/IL13 antagonists and immunoglobulins Chemistry; Metallurgy 69 Expired
US5777097A Oligonucleotides comprising a region of a cytokine suppressive anti-inflammatory drug binding protein Chemistry; Metallurgy 63 Expired
US5783664A Cytokine suppressive anit-inflammatory drug binding proteins Human Necessities 59 Expired
US5871934A Screening methods using cytokine suppressive anti-inflammatory drug (CSAID) binding proteins Chemistry; Metallurgy 57 Expired
US5869043A Drug binding protein Chemistry; Metallurgy 54 Expired
US6313269A Tumor necrosis factor related receptor, TR6 Chemistry; Metallurgy 50 Expired
US6153190A Erythropoietin receptor antibodies Chemistry; Metallurgy 43 Expired
US5955366A Polynucleotides encoding cytokine suppressive anti-inflammatory drug binding proteins Chemistry; Metallurgy 33 Expired
US9271978B2 Heterocyclic compounds as bromodomain inhibitors Emerging Cross-Sectional Technologies 29 Active
US9278940B2 Cyclic amines as bromodomain inhibitors Emerging Cross-Sectional Technologies 26 Active
US9765039B2 Biaryl derivatives as bromodomain inhibitors Emerging Cross-Sectional Technologies 24 Active
US5863769A DNA encoding interleukin-1 receptor antagonist (IL-1ra.beta.) Human Necessities 23 Expired
US9662311B2 Substituted bicyclic compounds as bromodomain inhibitors Emerging Cross-Sectional Technologies 23 Active
US9073878B2 Cyclic amines as bromodomain inhibitors Emerging Cross-Sectional Technologies 21 Active
US9861637B2 Heterocyclic compounds as bromodomain inhibitors Emerging Cross-Sectional Technologies 21 Active
US6998124B1 Erythropoietin receptor antibodies Chemistry; Metallurgy 20 Expired
US9636328B2 Substituted bicyclic compounds as bromodomain inhibitors Emerging Cross-Sectional Technologies 20 Active
US9598367B2 Heterocyclic compounds as bromodomain inhibitors Emerging Cross-Sectional Technologies 16 Active
US9663520B2 Bicyclic bromodomain inhibitors Emerging Cross-Sectional Technologies 16 Active
US6033873A Drug binding protein Chemistry; Metallurgy 13 Expired
US5945310A DNA encoding members of the IL-1 family, IL-1 delta Human Necessities 12 Expired
US5885800A DNA encoding tumor necrosis related receptor, TR4 Human Necessities 11 Expired
US6361773B1 Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins Human Necessities 10 Expired
US6054559A Interleukin-1 receptor antagonist beta (IL-1ra.beta.) Human Necessities 9 Expired
US6013476A DNA encoding tumor necrosis related receptor TR7 Physics 8 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.